![Mark Heselton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Heselton
Nessuna posizione attualmente
Profilo
Mark Heselton served as an Independent Director at Beleave, Inc. from 2018 to 2019.
He also worked as a Trustee at the University of Pittsburgh and as a Senior Vice President-Global Partner Business at Vifor Pharma AG.
Heselton received his undergraduate degree from Queen's University.
Precedenti posizioni note di Mark Heselton
Società | Posizione | Fine |
---|---|---|
BELEAVE INC. | Direttore/Membro del Consiglio | 19/02/2019 |
University of Pittsburgh | Direttore/Membro del Consiglio | - |
VIFOR PHARMA | Corporate Officer/Principal | - |
Formazione di Mark Heselton
Queen's University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BELEAVE INC. | Process Industries |
Aziende private | 1 |
---|---|
Vifor Pharma AG
![]() Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Mark Heselton